At the Tufts Obesity Clinic for Animals, part of our mission is to investigate why weight management is so challenging and how we can make weight loss safer for pets and easier for owners and veterinarians. Drs. Linder and Freeman have surveyed pet diets marketed for weight loss and published the results in the Journal of the American Veterinary Medical Association. They found that ‘light’ diets varied tremendously in calorie density, feeding directions, and price (for example, dry canine diets ranged from 217-440 kcal/cup). These results support the notion that having owners simply ‘switch to a light food is unlikely to be successful’ and depending on the current diet, might even lead pets to gain weight.
Insulinoma, a small and malignant neuroendocrine tumor of dogs, has proven difficult to detect reliably with imaging tests. The literature suggests that ultrasound detects a primary pancreatic lesion in approximately 50% of cases and detects metastases in only 20% of cases. CT has a reported success rate of detecting a primary lesion in 70% of cases, but is of limited value in the detection of metastases. Continue reading
Recently, the American Animal Hospital Association (AAHA) and the World Small Animal Hospital Association (WSAVA) Nutritional Guidelines were published. These guidelines were developed by committees that included Tufts Cummings School of Veterinary Medicine nutritionist, Dr. Lisa Freeman, as well as other nutritionists, veterinary practitioners, and scientists from multiple countries. Continue reading
Hypofractionated radiation therapy combined with the ONCEPT™ canine melanoma vaccine for canine oral melanoma
The Veterinary Radiation Therapy Oncology Group consists of a group of board-certified radiation oncologists across the nation dedicated to cooperative clinical trials to improve the survival of animals with cancer. The team at Tufts’ Foster Hospital for Small Animals is part of this consortium and is currently enrolling patients. This organization is currently conducting an independent study to evaluate the treatment of canine oral malignant melanoma with coarse-fraction radiotherapy (8 Gy for 4 weekly fractions) in combination with the ONCEPT™ melanoma vaccine. Data for three treatment groups (concurrent radiation therapy and vaccine; radiation therapy alone; vaccine alone) will be collected. Given that the study is not funded, treatment selection will be based on owners preference. The primary objective of this study is to compare tumor progression between the treatment groups with a secondary objective of evaluating overall survival time. Continue reading